🔹 Dividend King
Over 60 consecutive years increasing the annual dividend, a track record that few companies in the world can match.
🔹 Controlled payout
Even with consistent dividends, the company maintains a relatively low payout, ensuring room to reinvest and continue to grow dividend payments in the future (~57%).
🔹 Diversified business
Pharmaceuticals, medical devices and consumer goods: three areas that reduce risk and bring resilience in different phases of the economic cycle.
🔹 Global consumer brands
Tylenol, Band-Aid, Listerine, Neutrogena, Aveeno... a portfolio of strong brands, present in the daily lives of millions of people.
👉 I see JNJ as a pillar of stability in my dividend strategy.
